About Dhiren Thakker
Form D filings for MBF Therapeutics from 2021 to 2024 list Dhiren Thakker as director.
Dhiren Thakker first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Dhiren Thakker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dhiren Thakker works with at each company, as listed on that company's latest Form D.
MBF Therapeutics, Inc. · Form D, Jan 8, 2024
JC
Joseph Connor
Director
AP
Aris Persidis
Director
LK
Lorraine Keller
Executive officer
TT
Thomas Tillett
President and director
CC
Christopher Cashman
Director